A turn-on bis-BODIPY chemosensor for copper recognition based on the in situ generation of a benzimidazole-triazole receptor and its applications in bioimaging
Issued Date
2022-11-22
Resource Type
ISSN
11440546
eISSN
13699261
Scopus ID
2-s2.0-85142667414
Journal Title
New Journal of Chemistry
Volume
46
Issue
47
Start Page
22525
End Page
22532
Rights Holder(s)
SCOPUS
Bibliographic Citation
New Journal of Chemistry Vol.46 No.47 (2022) , 22525-22532
Suggested Citation
Saiyasombat W., Nuchpun S., Katewongsa K.P., Pornsuwan S., Weigand J.J., Kiatisevi S. A turn-on bis-BODIPY chemosensor for copper recognition based on the in situ generation of a benzimidazole-triazole receptor and its applications in bioimaging. New Journal of Chemistry Vol.46 No.47 (2022) , 22525-22532. 22532. doi:10.1039/d2nj04508g Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/84033
Title
A turn-on bis-BODIPY chemosensor for copper recognition based on the in situ generation of a benzimidazole-triazole receptor and its applications in bioimaging
Author's Affiliation
Other Contributor(s)
Abstract
A highly sensitive and selective off-on bis-BODIPY fluorescent sensor, BODIPY-NN, could be used to detect Cu2+ ions in aqueous solutions and to image intracellular Cu2+ ions in living cells. Upon addition of Cu2+ ions, BODIPY-NN showed a turn-on fluorescence response with 4-fold enhancement at 529 nm, indicating the inhibition of photo-induced electron transfer (PET) from the phenylenediamine-triazole unit to the BODIPY skeleton. This was triggered by oxidative C-N cyclization of phenylenediamine-triazole to in situ form a benzimidazole-triazole receptor providing an appropriate coordination environment that enhances metal ion binding efficiency. A mechanistic study revealed that Cu2+ acts as both a catalyst for oxidative C-N cyclization and a coordination center. The detection limit was determined to be 85 nM. Importantly, BODIPY-NN has been successfully utilized for fluorescence imaging of Cu2+ ions in MCF-7 cells and showed no toxicity toward MCF-7 cells. The non-cytotoxic nature and high sensitivity of BODIPY-NN pave a way for its use in in vivo studies as a promising fluorescent probe for high-performance sensing and bioimaging.